REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centrum Onkologii Bioinvent Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing | All Other Professional, Scientific, and Technical Services | Ambulatory Health Care Services
Full name: Centrum Onkologii Bioinvent Sp. z o.o. Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Centrum Onkologii Bioinvent Sp. z o.o. is based in Poland. The head office is in Poznan. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on April 18, 2012. 1 (2015) employees currently work for Centrum Onkologii Bioinvent Sp. z o.o.. The latest financial highlights indicate a net sales revenue drop of 50% in 2022. Over the same period, its total assets grew by 19.59%. In, 2022, the company’s net profit margin increased by 56.25%.

Headquarters
Ul. Grunwaldzka 50/27
Poznan; Wielkopolskie; Postal Code: 60-311

Contact Details: Purchase the Centrum Onkologii Bioinvent Sp. z o.o. report to view the information.

Website: http://www.centrum-onkologii.pl

Basic Information
Total Employees:
Purchase the Centrum Onkologii Bioinvent Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Centrum Onkologii Bioinvent Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Centrum Onkologii Bioinvent Sp. z o.o. report to view the information.
Incorporation Date:
April 18, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
87.2%
Purchase this report to view the information.
12.8%
Subsidiaries
Medycyna Molekularna Sp. z o.o.
10%
Company Performance
Financial values in the chart are available after Centrum Onkologii Bioinvent Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-50%▼
Total operating revenue
-50%▼
Operating profit (EBIT)
40%▲
Net Profit (Loss) for the Period
40%▲
Total assets
19.59%▲
Total equity
0%
Operating Profit Margin (ROS)
56.25%▲
Net Profit Margin
56.25%▲
Return on Equity (ROE)
44%▲

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Sartorius Stedim Poland Sp. z o.o.
 
Polpharma Biologics S.A.
Biomental Sp. z o.o.
 
Biosel Sp. z o.o.
Selvita Services Sp. z o.o.
 
Mu42 Sp. z o.o.
Delta Scientific Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo